You have 9 free searches left this month | for more free features.

Abemaciclib

Showing 26 - 50 of 198

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Breast Cancer Trial in Shanghai (Chidamide, Abemaciclib, Fulvestrant)

Recruiting
  • Breast Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 31, 2022

Breast Cancer Trial in Dallas (Letrozole, Abemaciclib)

Recruiting
  • Breast Cancer
  • Dallas, Texas
  • +1 more
Sep 30, 2022

Tumors Trial in Seoul (abemaciclib+paclitaxel)

Active, not recruiting
  • Tumors
  • Seoul, Korea, Republic of
    Severance Hospital
May 30, 2022

Clear Cell Renal Cell Carcinoma Trial in Boston (Abemaciclib, MK-6482)

Recruiting
  • Clear Cell Renal Cell Carcinoma
  • Boston, Massachusetts
  • +1 more
Dec 14, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Hormone Receptor Positive Breast Carcinoma, Metastatic Breast Carcinoma Trial in Duarte

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +3 more
  • Abemaciclib
  • Questionnaire Administration
  • Duarte, California
    City of Hope Medical Center
Nov 1, 2022

Myelofibrosis Due to and Following Polycythemia Vera Trial in United States (Ruxolitinib, Abemaciclib)

Recruiting
  • Myelofibrosis Due to and Following Polycythemia Vera
  • Basking Ridge, New Jersey
  • +6 more
Jan 26, 2023

Prostatic Tumors Trial in Germany, Spain, United States (Abemaciclib, Darolutamide, LHRH agonist/antagonist)

Not yet recruiting
  • Prostatic Neoplasms
  • Abemaciclib
  • +2 more
  • Mineola, New York
  • +14 more
Aug 23, 2023

Adenocarcinoma of Endometrium Trial in United States (Fulvestrant, Abemaciclib)

Recruiting
  • Adenocarcinoma of Endometrium
  • Basking Ridge, New Jersey
  • +6 more
Oct 12, 2022

Early-stage Breast Cancer, Diarrhea, Adverse Drug Event Trial in Sweden (SPC-flakes, Salovum, Placebo)

Recruiting
  • Early-stage Breast Cancer
  • +2 more
  • Eskilstuna, Sweden
  • +6 more
Nov 28, 2023

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in San

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +6 more
  • Abemaciclib
  • Lutetium Lu 177-PSMA-617
  • San Francisco, California
    University of California, San Francisco
Sep 8, 2022

Advanced Dedifferentiated Liposarcoma Trial in United States (Abemaciclib, Placebo)

Recruiting
  • Advanced Dedifferentiated Liposarcoma
  • Abemaciclib
  • Placebo
  • Jacksonville, Florida
  • +6 more
Jul 27, 2022

Metastatic Malignant Solid Tumor, Metastatic NUT Carcinoma, Unresectable Malignant Solid Tumor Trial (Abemaciclib, BET

Suspended
  • Metastatic Malignant Solid Neoplasm
  • +3 more
  • Abemaciclib
  • +3 more
  • Boston, Massachusetts
    Dana-Farber - Harvard Cancer Center LAO
Sep 17, 2022

Breast Cancer, Hormone Receptor-positive Breast Cancer, Hormone Receptor Positive HER-2 Negative Breast Cancer Trial in Boston

Not yet recruiting
  • Breast Cancer
  • +2 more
  • Boston, Massachusetts
  • +2 more
Nov 3, 2022

Breast Cancer Trial (ARV-471, Abemaciclib)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Feb 1, 2023

Metastatic Breast Cancer, Locally Advanced Breast Cancer, Hormone Receptor Positive Tumor Trial in Durham (Abemaciclib,

Recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Abemaciclib
  • +2 more
  • Durham, North Carolina
    Duke University Medical Center
Jun 7, 2022

HNSCC Trial in Tucson (Abemaciclib)

Recruiting
  • HNSCC
  • Abemaciclib
  • Tucson, Arizona
    University of Arizona
Mar 3, 2022

Breast Cancer Trial in Philadelphia (Abemaciclib, Hydroxychloroquine)

Recruiting
  • Breast Cancer
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Dec 13, 2021

Abemaciclib in Combination With Endocrine Therapy as First Line

Recruiting
  • Breast Cancer/ Metastatic Breast Cancer
  • Abemaciclib
  • Munich, Germany
    Klinikum rechts der Isar der TU München, Klinik und Poliklinik f
Apr 26, 2022

Prostate Cancer Trial in Birmingham (Abemaciclib 150 MG by mouth twice daily, Androgen deprivation therapy (ADT), Radiation

Recruiting
  • Prostate Cancer
  • Abemaciclib 150 MG by mouth twice daily
  • +2 more
  • Birmingham, Alabama
    University of Alabama at Birmingham (UAB)
Mar 18, 2022

Estrogen-receptor-positive Breast Cancer, HER2/Neu-Negative Breast Cancer, Advanced Breast Cancerv Trial in Chicago

Not yet recruiting
  • Estrogen-receptor-positive Breast Cancer
  • +3 more
  • elacestrant, palbociclib, abemaciclib, ribociclib
  • Chicago, Illinois
    Northwestern University
Sep 25, 2023

Breast Cancer Trial in Athens

Recruiting
  • Breast Cancer
    • Athens, Greece
      Hellenic Oncology Cooperative Group
    May 13, 2022

    Cancer Metastatic Trial in Pierre Benite, Rennes (Paclitaxel injection, Capecitabine tablets, Letrozole 2.5mg)

    Recruiting
    • Cancer Metastatic
    • Paclitaxel injection
    • +5 more
    • Pierre Benite, France
    • +1 more
    May 11, 2022

    Breast Cancer Trial in Aurora, Durham, Spokane Valley (Abemaciclib, Elacestrant)

    Recruiting
    • Breast Cancer
    • Aurora, Colorado
    • +2 more
    May 10, 2022

    Advanced Breast Cancer Trial in Lebanon (Fulvestrant, Neratinib, Alpelisib)

    Not yet recruiting
    • Advanced Breast Cancer
    • Lebanon, New Hampshire
      Dartmouth Hitchcock Medical Center
    Jun 28, 2023

    The Incidence of AEs and SAEs Receiving Verzenios® Over a Period of Approximately 24 Weeks Trial (Verzenios)

    Not yet recruiting
    • The Incidence of AEs and SAEs Receiving Verzenios® Over a Period of Approximately 24 Weeks
    • Verzenios
    • (no location specified)
    Mar 3, 2022